Kymera Therapeutics, Inc. (KYMR) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$81.44
Day's range
$85.71

Kymera Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 08/13/2026 12.35 M $1.42 B   5.55% 12.58%
BAKER BROS. ADVISORS LP 08/14/2026 8.66 M $992.73 M   0.00% 8.82%
AVORO CAPITAL ADVISORS LLC 08/14/2026 7.47 M $857.13 M   0.00% 7.61%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2026 7.11 M $815.65 M   17.36% 7.25%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 08/14/2026 6.26 M $717.52 M   14.50% 6.37%
BLACKROCK, INC. 08/07/2026 5.54 M $635.07 M   9.43% 5.64%
BVF INC/IL 08/14/2026 3.87 M $444.01 M   -29.63% 3.94%
WELLINGTON MANAGEMENT GROUP LLP 08/14/2026 3.68 M $421.42 M   -5.52% 3.74%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 2.99 M $343.11 M   4.11% 3.05%
SIREN, L.L.C. 08/13/2026 2.94 M $336.65 M   -7.88% 2.99%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 2.93 M $336.26 M   1.81% 2.99%
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC 08/13/2026 2.85 M $326.53 M   -37.80% 2.90%
STATE STREET CORP 08/07/2026 2.74 M $313.88 M   14.54% 2.79%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 1.82 M $208.32 M   10.39% 1.85%
CAPITAL RESEARCH GLOBAL INVESTORS 08/12/2026 1.39 M $159.26 M   -17.00% 1.41%
GOLDMAN SACHS GROUP INC 08/14/2026 1.19 M $136.15 M   33.65% 1.21%
UBS GROUP AG 08/13/2026 1.01 M $115.56 M   -1.57% 1.03%
ALLIANCEBERNSTEIN L.P. 08/14/2026 981.52 K $81.75 M   10.53% 1.00%
DRIEHAUS CAPITAL MANAGEMENT LLC 08/14/2026 919.23 K $105.41 M   -11.92% 0.94%
MERCK & CO., INC. 08/07/2026 772.17 K $88.54 M   0.00% 0.79%
NORGES BANK 08/12/2026 757.25 K $86.83 M   100.00% 0.77%
FEDERATED HERMES, INC. 08/12/2026 749.40 K $85.93 M   39.64% 0.76%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 745.15 K $85.42 M   25.68% 0.76%
FRONTIER CAPITAL MANAGEMENT CO LLC 08/14/2026 740.87 K $84.96 M   -2.50% 0.75%
UBS ASSET MANAGEMENT AMERICAS INC 08/13/2026 736.87 K $84.50 M   -15.87% 0.75%
HOLOCENE ADVISORS, LP 08/14/2026 636.58 K $73.00 M   -23.92% 0.65%
NORTHERN TRUST CORP 08/13/2026 581.91 K $66.73 M   17.69% 0.59%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 529.73 K $60.74 M   6.96% 0.54%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 529.73 K $60.74 M   100.00% 0.54%
FRANKLIN RESOURCES INC 08/13/2026 515.05 K $59.06 M   42.37% 0.52%
EVENTIDE ASSET MANAGEMENT, LLC 08/14/2026 504.21 K $57.81 M   -19.57% 0.51%
JENNISON ASSOCIATES LLC 08/03/2026 502.98 K $57.68 M   -1.18% 0.51%
WOODLINE PARTNERS LP 08/14/2026 500.87 K $57.43 M   146.02% 0.51%
ROCK SPRINGS CAPITAL MANAGEMENT LP 08/14/2026 453.16 K $51.96 M   -8.80% 0.46%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 449.73 K $51.57 M   5.23% 0.46%
BOXER CAPITAL MANAGEMENT, LLC 08/14/2026 429.10 K $49.20 M   30.39% 0.44%
PICTET ASSET MANAGEMENT HOLDING SA 07/30/2026 395.54 K $44.98 M   -15.61% 0.40%
BANK OF AMERICA CORP /DE/ 08/14/2026 378.29 K $43.38 M   30.71% 0.39%
BRAIDWELL LP 08/14/2026 378.16 K $43.36 M   12.03% 0.39%
BNP PARIBAS ARBITRAGE, SNC 08/13/2026 375.87 K $43.10 M   31.48% 0.38%
TWO SIGMA INVESTMENTS, LP 08/14/2026 371.37 K $42.59 M   44.78% 0.38%
CLEARBRIDGE INVESTMENTS, LLC 08/13/2026 347.22 K $39.82 M   100.00% 0.35%
OCTAGON CAPITAL ADVISORS LP 08/14/2026 310.00 K $35.55 M   -27.06% 0.32%
NEXTECH INVEST, LTD. 08/14/2026 278.90 K $31.98 M   0.00% 0.28%
ALYESKA INVESTMENT GROUP, L.P. 08/14/2026 276.46 K $31.70 M   -19.33% 0.28%
TD ASSET MANAGEMENT INC 08/04/2026 272.90 K $31.29 M   -4.95% 0.28%
VOYA INVESTMENT MANAGEMENT LLC 08/12/2026 269.91 K $30.95 M   35.77% 0.27%
COMMODORE CAPITAL LP 08/14/2026 250.00 K $28.67 M   -66.67% 0.25%
RTW INVESTMENTS, LP 08/14/2026 240.00 K $27.52 M   0.00% 0.24%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 08/03/2026 233.71 K $26.80 M   11.82% 0.24%

Kymera Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 337 institutional investors and hedge funds held shares of Kymera Therapeutics Inc. The most heavily invested institutionals were:

FMR LLC: 12.35 M

BAKER BROS. ADVISORS LP: 8.66 M

Avoro Capital Advisors LLC: 7.47 M

PRICE T ROWE ASSOCIATES INC /MD/: 7.11 M

T. Rowe Price Investment Management, Inc.: 6.26 M

BlackRock, Inc.: 5.54 M

99.35% of Kymera Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 110.27 M shares in the last 24 months. This purchase volume represents approximately $9.38 B in transactions.